In contrast, more BRCA2 reversion mutations were detected in breast cancer than BRCA1. Reversion mutations were reported in 30 out of 3424 tumors with BRCA1/2 mutations in ovarian cancer and 27 out of 1460 tumors with mutations in breast cancer. This evidence concerns the gene BRCA2 and breast cancer.